Wells Fargo Assumes Sabra Health Care REIT at Overweight, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst John Kilichowski has assumed coverage of Sabra Health Care REIT with an Overweight rating and increased the price target to $20.
October 01, 2024 | 2:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has assumed coverage of Sabra Health Care REIT with an Overweight rating and increased the price target to $20, indicating a positive outlook.
The Overweight rating and increased price target from a major financial institution like Wells Fargo suggest a positive outlook for Sabra Health Care REIT, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100